https://spiral.imperial.ac.uk/entities/publication/ea7f23a6-8473-4ee7-a454-eaae13995631
Therapeutic strategies to promote immune rejection of drug-resistant sub-populations in lung cancer
KRAS is the most frequently mutated oncogene in human cancer. Oncogenic KRAS signalling not only instigates aberrant growth in cancer cells but can further...
immune rejectiondrug resistantlung cancertherapeuticstrategies